Mercoledi mattina 12,30-13,30

Silvia Bellando Randone è Professore Associato di Reumatologia presso il Dipartimento di Medicina Sperimentale e Clinica dell’Università degli Studi di Firenze e svolge attività clinica presso la SOD di Reumatologia dell’AOU Careggi, dove è responsabile della Scleroderma Unit. È inoltre docente di Reumatologia presso la Scuola di Scienze della Salute Umana dell’Università di Firenze per i corsi di laurea in Medicina e Chirurgia, Infermieristica, Fisioterapia e Tecniche Ortopediche. 

La sua attività clinica e scientifica è principalmente dedicata alla sclerosi sistemica e alle malattie del connettivo, con particolare interesse per la diagnosi precoce della sclerosi sistemica (VEDOSS), le interstiziopatie polmonari associate a connettiviti, il coinvolgimento gastrointestinale e i biomarcatori di malattia.

Partecipa a numerose collaborazioni nazionali e internazionali nell’ambito della ricerca clinica e traslazionale sulle malattie autoimmuni sistemiche ed è membro di network scientifici internazionali dedicati alla sclerosi sistemica, tra cui EUSTAR (European Scleroderma Trials and Research Group), SCTC (Scleroderma Clinical Trials Consortium) ed ERN ReCONNET (European Reference Network on Rare and Complex Connective Tissue and Musculoskeletal Diseases).

È autrice e coautrice di numerose pubblicazioni scientifiche su riviste internazionali peer-reviewed e svolge attività di revisore per diverse riviste scientifiche internazionali in ambito reumatologico. È inoltre membro dell’Editorial Board del Journal of Scleroderma and Related Disorders (JSRD).

Dal 2024 è membro del Consiglio Direttivo della Società Italiana di Reumatologia (SIR).

Silvia Bellando Randone is Associate Professor of Rheumatology at the Department of Experimental and Clinical Medicine, University of Florence, and works at the Rheumatology Unit of Careggi University Hospital, where she is Head of the Scleroderma Unit. She is also Lecturer in Rheumatology at the School of Medicine of the University of Florence for the Degree Courses in Medicine and Surgery, Nursing, Physiotherapy, and Orthopaedic Techniques.

Her clinical and scientific activity is mainly focused on systemic sclerosis and connective tissue diseases, with particular interest in the very early diagnosis of systemic sclerosis (VEDOSS), connective tissue disease-associated interstitial lung disease, gastrointestinal involvement, and disease biomarkers.

She is involved in several national and international collaborations in the field of clinical and translational research on systemic autoimmune diseases and is a member of international scientific networks dedicated to systemic sclerosis, including EUSTAR (European Scleroderma Trials and Research Group), SCTC (Scleroderma Clinical Trials Consortium), and ERN ReCONNET (European Reference Network on Rare and Complex Connective Tissue and Musculoskeletal Diseases).

She is author and co-author of numerous scientific publications in international peer-reviewed journals and serves as reviewer for several international rheumatology journals. She is also a member of the Editorial Board of the Journal of Scleroderma and Related Disorders (JSRD).

Since 2024, she has been a member of the Executive Board of the Italian Society of Rheumatology (SIR).

Elenco pubblicazioni

1. G. Carnesecchi, S. Bellando Randone, M. Matucci Cerinic.Utilità diagnostica e prognostica della tipizzazione tissutale nell’artrite reumatoide Rheumatoid Arthritis Magazine 2007; 3: 17-29
2. Randone SB, Guiducci S, Cerinic MM.  Musculoskeletal involvement in systemic sclerosis.   Best Pract Res Clin Rheumatol. 2008 Apr;22(2):339-50 IF 2.653
3. Randone SB, Guiducci S, Cerinic MM. Systemic sclerosis and infections. Autoimmun Rev. 2008 Oct;8(1):36-40 IF 6.624
4. Bellando Randone S, Cutolo M., Czirjak L., Matucci Cerinic M.. Mixed Connective Tissue Disease, a roundabout to rheumatic diseases?” Current Rheumatology Reviews, 2009, Volume 5, No. 2 (May issue) 133-140 
5. Guiducci S, Porta F, Saccardi R, Guidi S, Ibba-Manneschi L, Manetti M, Mazzanti B, Dal Pozzo S, MiliaAF, Bellando-Randone S, Miniati I, Fiori G, Fontana R, Amanzi L, Braschi F, Bosi A, Matucci-CerinicM. Autologous mesenchymal stem cells foster revascularization of ischemic limbs in systemic sclerosis: acase report. Ann Intern Med. 2010 Nov 16;153(10):650-4 IF 16.733

6. Avouac J, Fransen J, Walker UA, Riccieri V, Smith V, Muller C, Miniati I, Tarner IH, Randone SB, Cutolo M, Allanore Y, Distler O, Valentini G, Czirjak L, Müller-Ladner U, Furst DE, Tyndall A, Matucci-Cerinic M; EUSTAR Group. Preliminary criteria for the very early diagnosis of systemic sclerosis: results of a Delphi Consensus Study from EULAR Scleroderma Trials and Research Group. Ann Rheum Dis. 2011 Mar;70(3):476-81 IF 8.727
7. Manetti M, Guiducci S, Ceccarelli C, Romano E, Bellando-Randone S, Conforti ML, Ibba-Manneschi L, Matucci-Cerinic M. Increased circulating levels of interleukin 33 in systemic sclerosis correlate with early disease stage and microvascular involvement. Ann Rheum Dis. 2011 Oct;70(10):1876-8. Epub 2011 May 12 IF 8.727.
8. Bellando-Randone S, Lepri G, Bruni C, Blagojevic J, Radicati A, Cometi L, De Paulis A, Matucci-Cerinic M, Guiducci S. Combination therapy with Bosentan and Sildenafil improves Raynaud's phenomenon and fosters the recovery of microvascular involvement in systemic sclerosis. Clin Rheumatol. 2016 Jan;35(1):127-32. doi: 10.1007/s10067-015-3119-3
9. Blagojevic J, Piemonte G, Benelli L, Braschi F, Fiori G, Bartoli F, Guiducci S, Bellando Randone S, Galluccio F, Cometi L, Castellani S, Boddi M, Moggi Pignone A, Rasero L, Epifani F, Matucci-Cerinic M. Assessment, Definition, and Classification of Lower Limb Ulcers in Systemic Sclerosis: A Challenge for the Rheumatologist. J Rheumatol. 2016 Mar;43(3):592-8. doi: 10.3899/jrheum.150035
10. Guiducci S, Bellando-Randone S, Matucci-Cerinic M. A New Way of Thinking about Systemic Sclerosis: The Opportunity for a Very Early Diagnosis. Isr Med Assoc J. 2016 Mar-Apr;18(3-4):141-3.
11. Bartoli F, Fiori G, Braschi F, Amanzi L, Bruni C, Blagojevic J, Bellando-Randone S, Cometi L, de Souza Mueller C, Guiducci S, Rasero L, Epifani F, Furst DE, Matucci-Cerinic M Calcinosis in systemic sclerosis: subsets, distribution and complications Rheumatology (Oxford). 2016 Sep;55(9):1610-4. doi: 10.1093/rheumatology/kew193
12. Bruni C, Bellando-Randone S, Gargani L, Picano E, Pingitore A, Matucci-Cerinic M, Guiducci S. Critical finger ischemia and myocardial fibrosis development after sudden interruption of sildenafil treatment in a systemic sclerosis patient. Reumatismo. 2016 Sep 9;68(2):109-11. Doi: 10.4081/reumatismo.2016.889.
13. Lepri G, Avouac J, Airò P, Anguita Santos F, Bellando-Randone S, Blagojevic J, Garcia Hernàndez F, Gonzalez Nieto JA, Guiducci S, Jordan S, Limaye V, Maurer B, Selva-O'Callaghan A, Riccieri V, Distler O, Matucci-Cerinic M, Allanore Y. Effects of rituximab in connective tissue disorders related interstitial lung disease. Clin Exp Rheumatol. 2016 Sep-Oct;34 Suppl 100(5):181-18
14. Bruni C, Praino E, Guiducci S, Bellando-Randone S, Furst DE, Matucci-Cerinic M. Hydroxychloroquine and joint involvement in systemic sclerosis: Preliminary beneficial results from a retrospective case-control series of an EUSTAR center. Joint Bone Spine. 2016 Dec 5. pii: S1297-319X(16)30179-8. doi: 10.1016/j.jbspin.2016.10.0
15. Bruni C, Guiducci S, Bellando-Randone S, Matucci-Cerinic M. Avascular bone necrosis: An underestimated complication of systemic sclerosis. Semin Arthritis Rheum. 2017 Aug;47(1):e3-e5. doi: 10.1016/j.semarthrit.2017.03.015.
16. Mazzotta C, Manetti M, Rosa I, Romano E, Blagojevic J, Bellando-Randone S, Bruni C, Lepri G, Guiducci S, Ibba-Manneschi L, Matucci-Cerinic M. Proangiogenic effects of soluble α-Klotho on systemic sclerosis dermal microvascular endothelial cells Arthritis Res Ther. 2017 Feb 10;19(1):27. doi: 10.1186/s13075-017-1233-0
17. Manetti M, Romano E, Rosa I, Guiducci S, Bellando-Randone S, De Paulis A, Ibba-Manneschi L, Matucci-Cerinic M. Endothelial-to-mesenchymal transition contributes to endothelial dysfunction and dermal fibrosis in systemic sclerosis.Ann Rheum Dis. 2017 May;76(5):924-934. doi: 10.1136/annrheumdis-2016-210229. Epub 2017 Jan 6
18. Matucci-Cerinic M, Manetti M, Bruni C, Chora I, Bellando-Randone S, Lepri G, De Paulis A, Guiducci S. The "myth" of loss of angiogenesis in systemic sclerosis: a pivotal early pathogenetic process or just a late unavoidable event? Arthritis Res Ther. 2017 Jul 6;19(1):162. doi: 10.1186/s13075-017-1370-5
19. Bellando Randone S, George J, Mazzotta C, Guiducci S, Furst F, Mor A,  Matucci Cerinic M. Angiostatic and angiogenic chemokines in systemic sclerosis: an overview 2017 JSRD DOI:10.5301/jsrd.5000226
20. Manetti M, Pratesi S, Romano E, Bellando-Randone S, Rosa I, Guiducci S, Fioretto BS, Ibba-Manneschi L, Maggi E, Matucci-Cerinic M. Angiogenic T cell expansion correlates with severity of peripheral vascular damage in systemic sclerosis.PLoS One. 2017 Aug 10;12(8):e0183102
21. Bellando-Randone S, Matucci-Cerinic M. Very Early Systemic Sclerosis and Pre-systemic Sclerosis: Definition, Recognition, Clinical Relevance and Future Directions. Curr Rheumatol Rep. 2017 Sep 18;19(10):65

1. S. Bellando Randone, S. Guiducci , M. Matucci Cerinic Patient subgroups and potential risk factors in SSc:is there a possibility of an early diagnosis ? Int. J. Clin. Rheumatol. 2010 5(5), 555-564

1. Bernardo P, Conforti ML, Bellando-Randone S, Pieragnoli P, Blagojevic J, Kaloudi O, Guiducci S, Porta F, Padeletti L, Gensini GF, Matucci-Cerinic M. Implantable Cardioverter Defibrillator Prevents Sudden Cardiac Death in Systemic Sclerosis. J Rheumatol. 2011 Aug;38(8):1617-21. Epub 2011 Jun 1. IF 3.695
2. Manetti M, Guiducci S, Romano E, Ceccarelli C, Bellando-Randone S, Conforti ML, Ibba-Manneschi L, Matucci-Cerinic M. Overexpression of VEGF165b, an Inhibitory Splice Variant of Vascular Endothelial Growth Factor, Leads to Insufficient Angiogenesis in Patients With Systemic Sclerosis. Circ Res. 2011 Jul 22;109(3):e14-26. Epub 2011 Jun 2. IF 9.489
3. Guiducci S, Manetti M, Romano E, Mazzanti B, Ceccarelli C, Dal Pozzo S, Milia AF, Bellando-Randone S, Fiori G, Conforti ML, Saccardi R, Ibba-Manneschi L, Matucci-Cerinic M. Bone marrow-derived mesenchymal stem cells from early diffuse systemic sclerosis exhibit a paracrine machinery and stimulate angiogenesis in vitro. Ann Rheum Dis. 2011 Nov;70(11):2011-21. Epub 2011 Aug 6. IF 8.727
4. Cappelli S, Bellando Randone S, Martinović D, Tamas MM, Pasalić K, Allanore Y, Mosca M, Talarico R, Opris D, Kiss CG, Tausche AK, Cardarelli S, Riccieri V, Koneva O, Cuomo G, Becker MO, Sulli A, Guiducci S, Radić M, Bombardieri S, Aringer M, Cozzi F, Valesini G, Ananyeva L, Valentini G, Riemekasten G, Cutolo M, Ionescu R, Czirják L, Damjanov N, Rednic S, Matucci Cerinic M. "To be or not  to be," ten years after: evidence for mixed connective tissue disease as a distinct entity. Semin Arthritis Rheum. 2012 Feb;41(4):589-98. Epub 2011 Sep 29 IF 4.969.
5. Manetti M, Guiducci S, Romano E, Bellando-Randone S, Conforti ML, Ibba-Manneschi L, Matucci-Cerinic M. Increased serum levels and tissue expression of matrix metalloproteinase-12 in patients with systemic sclerosis: correlation with severity of skin and pulmonary fibrosis and vascular damage. Ann Rheum Dis. 2012 Jun;71(6):1064-72 IF 8.727.
6. Bellando-Randone S, Guiducci S, Matucci-Cerinic M. ” Very early diagnosis of systemic sclerosis” Pol Arch Med Wewn. 2012;122 Suppl 1:18-23 IF 1.367
7. Guiducci S., Bellando Randone  S., Bruni C., Carnesecchi G., Maresta A., Iannone F., Lapadula G.,  Matucci Cerinic M. Bosentan fosters microvascular de-remodelling in systemic sclerosis. Clinical Rheumatology 2012 Dec;31(12):1723-5 IF 1.996
8. Matucci-Cerinic M, Bellando-Randone S., Lepri G, Bruni C,  Guiducci S.  “Very early versus early  disease: the evolving definition of the many faces of Systemic Sclerosis.” Ann Rheum Dis 2013, Mar;72(3):319-21  IF 8.727.
9. Barskova T, Gargani L, Guiducci S, Randone SB, Bruni C, Carnesecchi G, Conforti ML, Porta F, Pignone A, Caramella D, Picano E, Cerinic MM. “Lung ultrasound for the screening of interstitial lung disease in very early systemic sclerosis.” Ann Rheum Dis. 2013 Mar;72(3):390-5 IF 8.727.
10. Pingitore A., Guiducci S., Conforti M.L., De Marchi D., Gargani L., Moggi-Pignone A., Randone SB., Lombardi M., Picano E.  Matucci-Cerinic M. Early detection of myocardial and pulmonary oedema with MRI in an asymptomatic systemic sclerosis patient: successful recovery with pulse steroid. Rheumatology (Oxford) 2013 March 12 IF 4.058.
11. ManettiM., GuiducciS., RomanoE., Bellando-RandoneS., Lepri G, Bruni C, ConfortiM.L., Ibba-Manneschi L., Matucci-CerinicM. Increased plasma levels of the VEGF₁₆₅b splice variant are associated with the severity of nailfold capillary loss in systemic sclerosis Ann Rheum Dis. 2013 Apr 9 IF 8.727.
12. Minier T., Guiducci S., Bellando Randone S., Bruni C., Lepri G., et al. “Preliminary analysis of the Very Early diagnosis of Systemic Sclerosis (VEDOSS) EUSTAR multicentre study: evidence for puffy fingers as pivotal sign for the suspicion of systemic sclerosis”, Ann Rheum Dis, 2013 Aug 12
13. Bellando Randone S., GuiducciS.,  ConfortiM.L., BlagojevicJ., SalvadoriniG., FioriG., BartoliF., NacciF., CandelieriA,, BruniC., Moggi PignoneA., Matucci Cerinic M. Sildenafil and Raynaud’s phenomenon (RP) in Systemic Sclerosis (SSc): results from a retrospective study.  European Journal Muscoloskeletal Diseases, 21-26 2013
14. Tani C, Bellando Randone S, Guiducci S, Della Rossa A. Systemic sclerosis: a critical digest of the recent literature. Clin Exp Rheumatol. 2013 Mar-Apr;31(2 Suppl 76):172-9. Epub 2013 Jul 23
15. Cappelli S, Guiducci S, Bellando Randone S,  Matucci Cerininc Immunosuppression for interstitial lung disease in Systemic sclerosis" European Respiratory review, 2013 Sep 1;22(129):236-43.
16. Cappelli S, Bellando-Randone S, Guiducci S, Matucci-Cerinic M. Is immunosuppressive therapy the anchor treatment to achieve remission in systemic sclerosis?Rheumatology (Oxford). 2013 Oct 31
17. Bellando-Randone S, Cappelli S, Guiducci S, Cometi L &Matucci-Cerinic M. Treatment options in systemic sclerosis. Expert Opinion on Orphan Drugs 2013 851-865 d
18. Manetti M, Guiducci S, Romano E, Avouac J, Rosa I, Ruiz B, Lepri G, Bellando-Randone S, Ibba-Manneschi L, Allanore Y, Matucci-Cerinic M. Decreased expression of the endothelial cell-derived factor EGFL7 in systemic sclerosis: potential contribution to impaired angiogenesis and vasculogenesis. Arthritis Res Ther. 2013 Oct 25;15(5):R165
19. Bellando Randone S, Guiducci S., Matucci Cerinic M,. From Raynaud’s Phenomenon to Very early diagnosis of Systemic Sclerosis- The VEDOSS approach. Current Rheum Rev 2013 9,245-248
20. Romano E, Manetti M, Peruzzi F, Melchiorre D, Milia AF, Bellando-Randone S, Nishioka K, Innocenti M, Carulli C, Linari S, Morfini M, Ibba-Manneschi L, Matucci-Cerinic M, Guiducci S. Agonistic anti-human Fas monoclonal antibody induces fibroblast-like synoviocyte apoptosis in haemophilic arthropathy: potential therapeutic implications. Haemophilia. 2014 Jan;20(1):e32-9. doi: 10.1111/hae.12304
21. Susanna C. , Philippe G, Silvia BR, Ginevra F, Francesca B, Jelena B, Francesca N, Letizia CM, Francesca B, Loic G, Marco MC¹ Transitional connective tissue diseases: description of four cases. Curr Rheumatol Rev. 2014;10(2):94-8
22. van Laar JM, Farge D, Sont JK, Naraghi K, Marjanovic Z, Larghero J, Schuerwegh AJ, Marijt EW, Vonk MC, Schattenberg AV, Matucci-Cerinic M, Voskuyl AE, van de Loosdrecht AA, Daikeler T, Kötter I, Schmalzing M, Martin T, Lioure B, Weiner SM, Kreuter A, Deligny C, Durand JM, Emery P, Machold KP, Sarrot-Reynauld F, Warnatz K, Adoue DF, Constans J, Tony HP, Del Papa N, Fassas A, Himsel A, Launay D, Lo Monaco A, Philippe P, Quéré I, Rich É, Westhovens R, Griffiths B, Saccardi R, van den Hoogen FH, Fibbe WE, Socié G, Gratwohl A, Tyndall A; EBMT/EULAR Scleroderma Study Group. Autologous hematopoietic stem cell transplantation vs intravenous pulse cyclophosphamide in diffuse cutaneous systemic sclerosis: a randomized clinical trial. JAMA. 2014 Jun 25;311(24):2490-8
23. Romano E, Terenzi R, Manetti M, Peruzzi F, Fiori G, Nacci F, Bellando-Randone S, Matucci-Cerinic M, Guiducci S. Disease activity improvement in rheumatoid arthritis treated with tumor necrosis factor-α inhibitors correlates with increased soluble Fas levels J Rheumatol. 2014 Oct;41(10):1961-5
24. Barsotti S, Bellando Randone S, Guiducci S, Della Rossa A. Systemic sclerosis: a critical digest of the recent literature Clin Exp Rheumatol. 2014 Nov-Dec;32(6 Suppl 86):S194-205
25. Lepri G, Guiducci S, Bellando-Randone S, Giani I, Bruni C, Blagojevic J, Carnesecchi G, Radicati A, Pucciani F, Marco MC. Evidence for oesophageal and anorectal involvement in very early systemic sclerosis (VEDOSS): report from a single VEDOSS/EUSTAR centre. Ann Rheum Dis.2015 Jan;74(1):124-8. doi: 10.1136/annrheumdis-2013-203889
26. Bruni C, Guiducci S, Bellando-Randone S, Lepri G, Braschi F, Fiori G, Bartoli F, Peruzzi F, Blagojevic J, Matucci-Cerinic M. Digital ulcers as a sentinel sign for early internal organ involvement in very early systemic sclerosis.Rheumatology (Oxford). 2015 Jan;54(1):72-6
27. Chora I, Guiducci S, Manetti M, Romano E, Mazzotta C, Bellando-Randone S, Ibba-Manneschi L, Matucci-Cerinic M, Soares R. Vascular biomarkers and correlation with peripheral vasculopathy in systemic sclerosis.Autoimmun Rev. 2015 Apr;14(4):314-22
28. Hachulla E, Clerson P, Airò P, Cuomo G, Allanore Y, Caramaschi P, Rosato E, Carreira PE, Riccieri V, Sarraco M, Denton CP, Riemekasten G, Pozzi MR, Zeni S, Mihai CM, Ullman S, Distler O, Rednic S, Smith V, Walker UA, Matucci-Cerinic M, Müller-Ladner U, Launay D; EUSTAR co-workers. Value of systolic pulmonary arterial pressure as a prognostic factor of death in the systemic sclerosis EUSTAR population Rheumatology (Oxford). 2015 Jul;54(7):1262-9.
29. Hizal M, Bruni C, Romano E, Mazzotta C, Guiducci S, Bellando Randone S, Blagojevic J, Lepri G, Tufan A, Matucci Cerinic M. Decrease of LL-37 in systemic sclerosis: a new marker for interstitial lung disease?Clin Rheumatol. 2015 Apr;34(4):795-8
30. Mihai C, Landewé R, van der Heijde D, Walker UA, Constantin PI, Gherghe AM, Ionescu R, Rednic S, Allanore Y, Avouac J, Czirják L, Hachulla E, Riemekasten G, Cozzi F, Airò P, Cutolo M, Mueller-Ladner U, Matucci-Cerinic M; EUSTAR co-authors. Digital ulcers predict a worse disease course in patients with systemic sclerosis. Ann Rheum Dis. 2016 Apr;75(4):681-6. doi: 10.1136/annrheumdis-2014-205897
31. Borghini A, Manetti M, Nacci F, Bellando-Randone S, Guiducci S, Matucci-Cerinic M, Ibba-Manneschi L, Weber E. Systemic Sclerosis Sera Impair Angiogenic Performance of Dermal Microvascular Endothelial Cells: Therapeutic Implications of Cyclophosphamide PLoS One. 2015 Jun 15;10(6):e0130166
32. Romano E, Bellando-Randone S, Manetti M, Bruni C, Lepri G, Matucci-Cerinic M, Guiducci S.  Bosentan blocks the antiangiogenic effects of sera from systemic sclerosis patients: an in vitro study. Clin Exp Rheumatol. 2015 Jul-Aug;33 Suppl 91(4):148-52. Epub 2015 Jun 19
33. Mazzotta C, Romano E, Bruni C, Manetti M, Lepri G, Bellando-Randone S, Blagojevic J, Ibba-Manneschi L, Matucci-Cerinic M, Guiducci S. Plexin-D1/Semaphorin 3E pathway may contribute to dysregulation of vascular tone control and defective angiogenesis in systemic sclerosis.Arthritis Res Ther. 2015 Aug 21;17:221
34. Cappelli S, Bellando Randone S, Camiciottoli G, De Paulis A, Guiducci S, Matucci-Cerinic M. Interstitial lung disease in systemic sclerosis: where do we stand?Eur Respir Rev. 2015 Sep;24(137):411-9
35. Romano E, Chora I, Manetti M, Mazzotta C, Rosa I, Bellando-Randone S, Blagojevic J, Soares R, Avouac J, Allanore Y, Ibba-Manneschi L, Matucci-Cerinic M, Guiducci S. Decreased expression of neuropilin-1 as a novel key factor contributing to peripheral microvasculopathy and defective angiogenesis in systemic sclerosis.Ann Rheum Dis. 2015 Sep 10. pii: annrheumdis-2015-207483. doi: 10.1136/annrheumdis
36. Bruni C, Lepri G, Peruzzi F, Bellando-Randone S, Radicati A, Matucci-Cerinic M, Guiducci S. Antioxidant agents help primary Raynaud's phenomenon. Int Angiol. 2015 Feb;34(1):94-5.
37. Blagojevic J, Piemonte G, Benelli L, Braschi F, Fiori G, Bartoli F, Guiducci S, Bellando Randone S, Galluccio F, Cometi L, Castellani S, ,Boddi, Moggi Pignone A, Rasero L, Epifani F and Matucci Cerinic M Assessment, Definition, and Classification of Lower Limb Ulcers in Systemic: A Challenge for the Rheumatologist. J Rheumatol 2016;43;592-598
38. Bellando-Randone S, Lepri G., Bruni C.,  Blagojevic J.,  Radicati A., Cometi. L.,  De Paulis A., Matucci-Cerinic M1 &  Guiducci SCombination therapy with Bosentan and Sildenafil improves Raynaud’s phenomenon and fosters the recovery of microvascular involvement in systemic sclerosis Clin Rheumatol (2016) 35:127–132DOI 10.1007/s10067-015-3119-3
39. Cantini F, Niccoli L, Nannini C, Cassarà E, Kaloudi O, Giulio Favalli E, Becciolini A, Biggioggero M, Benucci M, Li Gobbi F, Grossi V, Infantino M, Meacci F, Manfredi M, Guiducci S, Bellando-Randone S, Matucci-Cerinic M, Foti R, Di Gangi M, Mosca M, Tani C, Palmieri F, Goletti D; Italian board for the TAilored BIOlogic therapy (ITABIO). Tailored first-line biologic therapy in patients with rheumatoid arthritis, spondyloarthritis, and psoriatic arthritis. Semin Arthritis Rheum. 2015 Oct 22. pii:   S0049-0172(15)00241-3. doi: 10.1016/j

CAPITOLI IN LIBRI

1. S. Bellando Randone, S. Guiducci, M. Matucci Cerinic. Topoisomerase-I (Scl-70) autoantibodies. Chapter 31 of Book:Autoantibodies eds Y Shoenfeld, PL Meroni, e N Rosen 2007
2. S. Bellando Randone, S. Guiducci, M Matucci Cerinic. The microcirculation and Rheumatic Diseases. Chapter of book: Atlas of Capilaroscopy in Rheumatic Diseases by Maurizio Cutolo 2010.
3. S. Guiducci, S. Bellando Randone, M Matucci Cerinic. Autoantibodies in systemic sclerosis. Chapter of book: Autoimmunity by Y Shoenfeld and N Rose 2009
4. Lepri G., Bellando Randone S, Bruni C., Matucci Cerinic M, Guiducci S. Very and Early diagnosis of systemic sclerosis. Chapter in e-book: Novel insights into systemic sclerosis management.Editori: Maurizio Cutolo & Vanessa Smith. www.futurescience.comPages 52-60(doi: 10.2217/ebo.13.169)
5. Guiducci S,  Manetti M., Romano E., Bellando Randone S.,  Ibba Manneschi L.. Stiff Skin Syndrome. Chapter of book: Skin Manifestations in Rheumatic Disease. Springer science. 2013
6. Bellando Randone, S. Guiducci, M Matucci Cerinic Diagnostico y clasificacion de la esclerosis sistémica (esclerodermia) Chapetr of book: Manial SER  Editor Jefe , 191-195 2014
7. Bellando Randone S., Little Jayne, Herrick A., Matucci Cerinic. Microvascular and macrovascular disease in systemic sclerosis, with reference to the digits. Eular Text book on Systemic Sclerosis 139-148 BMJ Eiditor HAchulla E. www.eular-onlinecourse.org 2013
8. Bellando Randone S., Furst DE., Matucci Cerinic. Very early and early systemic sclerosis. Eular Text book on Systemic Sclerosis 357-363 BMJ Eiditor HAchulla E. www.eular-onlinecourse.org 2013
9. Lepri G., Bellando Randone S., Distler JH Connective Tissue Diseases: concept and overlap syndromes Eular Text book on Rheumatic Diseases second edition  509-530 BMJ Eiditors Bijlsma JWJ and HAchulla E. www.eular-onlinecourse.org 2015
10. Miniati I , Bellando Randone S, MAtucci Cerinic M  “la sclerosis sistemica” .La riabilitazione multidisciplinare del malato reumatico Maddali e Bruni Editore 2016

Data 18 Settembre 2017